Table 6
(continued)
PHA
Structure preparation
Structure
morphology
Tested for
Refs.
Solvent
Polymer
concentration
Additive
Phase
inversion
P(3HB3HV) (12 mol% HV)
Methylene chloride
5 wt%
Blended with
PLA under
different ratio
Evaporation
From dense to
porous
depending of
the PLA/PHA
ratio
Biomedical
application
Santos
et al.
(2004)
P(3HB)
Chloroform
3 wt%
Glass particles
Evaporation
Porous
symmetric
Biomedical
application
Misra
et al.
(2008)
P(3HB) (Mn = 450,000 g/mol)
Chloroform
n.i
Blended with
poly
(p-dioxane)
under different
ratio
Evaporation
Porous
Biomedical
application
Dias
et al.
(2008)
P(3HB) (Mw = 430,000 g/mol)
(Mn = 290,000 g/mol) (Ip = 1.49)
Chloroform
3% w/v
Blended with
PEG under
different ratio
Evaporation
n.i
Biomedical
application
Cheng
et al.
(2003)
P(3HB) (Mw = 437,000 g/mol)
Chloroform
0.5%, 1%,
2%, 3% w/v
None
VIPS
Porous.
nanofibrous
aerogel
Control
structure
scaffold
Kang
et al.
(2016)
P(3HB)
Chloroform/methanol
0.045 mol/L
CuCl
2 and
NiCl
2
Evaporation
Porous
Control
structure
scaffold
Tan et al.
(2016)
P(3HB3HV) (3 mol% HV)
(Mw = 303,000 g/mol)
Chloroform
5% w/v
None
Evaporation
Dense
Sorption
diffusion of
water
Follain
et al.
(2014)
P(3HB3HHx) (17 mol% 3HHx) and P
(3HB3HHx) (30 mol% 3HHx)
MIBK
2.5% w/v
None
Evaporation
Porous
symmetric
Antibiofilm
materials
Kehail
and
Brigham
(2017)
P(3HB) (Mw = 600,000 g/mol) and P(3HB3HV)
(12 mol% HV) (Mw = 252,000 g/mol)
Chloroform
2% w/v
Diethylene
glycol
Evaporation
Porous
Improved
biocompatible
material
Chan
et al.
(2013)
P(3HB)
Chloroform
n.i
Bacterial
cellulose
Evaporation
Dense to
porous
composites
Improved
mechanical
properties
Barud
et al.
(2011)
Polyhydroxyalkanoates (PHAs) for the Fabrication …
187